The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Valneva SE, a specialty vaccine company, announced that the United Arab Emirates (UAE) granted emergency use authorization for Valneva’s inactivated, ...
read more
Mitsubishi Tanabe Pharma America, Inc. (MTPA) announced the FDA has approved RADICAVA ORS® (edaravone), the oral form of edaravone, for the treatment ...
read more
The FDA approved a new indication for Olumiant (baricitinib) for the treatment of COVID-19 in hospitalized adults requiring supplemental oxygen, non-...
read more
AUM Biosciences, a global clinical-stage biotech company focused on discovering and developing novel targeted oncology therapies, has entered into a ...
read more
The FDA has limited the authorized use of the Janssen COVID-19 Vaccine to individuals 18 years of age and older for whom other authorized or approved ...
read more
Acer Therapeutics Inc., a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and life-...
read more
Belite Bio, Inc, a San Diego based clinical stage biopharmaceutical drug development company targeting currently untreatable eye diseases, such as ...
read more
Bayer announced that the FDA has accepted a supplemental New Drug Application (sNDA) and granted Priority Review for the oral androgen receptor ...
read more
Fresenius Kabi has introduced Bortezomib for Injection, a new generic equivalent to Velcade® in the U.S. and the newest addition to the most ...
read more
Worldwide Clinical Trials, Inc. a midsize, full-service contract research organization (CRO), announced that Rosemarie Corrigan has joined the company...
read more
Vitti Labs, an AATB Accredited Tissue Bank focused on life Science Research, development, and manufacturing, announced that the U.S. Food and Drug ...
read more
Vaxxinity, Inc. announced that UB-311, an anti-amyloid beta immunotherapeutic vaccine, has been granted Fast Track designation by the U.S. Food and ...
read more
Merck announced that the European Commission has approved KEYTRUDA, Merck’s anti-PD-1 therapy, as monotherapy for the treatment of microsatellite ...
read more
AstraZeneca announced plans to open a new site at the heart of the Cambridge, MA, life sciences and innovation hub.
read more
Bristol Myers Squibb announced that the U.S. Food and Drug Administration (FDA) approved Camzyos™ (mavacamten, 2.5 mg, 5 mg, 10 mg, 15 mg capsules) ...
read more